Susan A. Knudson - 07 Nov 2022 Form 4 Insider Report for Histogen Inc.

Role
EVP, CFO & Corp Secy
Signature
/s/ Susan A. Knudson
Issuer symbol
N/A
Transactions as of
07 Nov 2022
Net transactions value
-$1,714,500
Form type
4
Filing time
09 Nov 2022, 15:30:39 UTC
Previous filing
22 Feb 2022
Next filing
14 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Restricted Stock Units Disposed to Issuer $1,714,500 -6,858 -100% $250.00* 0 07 Nov 2022 Common Stock 6,858 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On November 7, 2022, the Issuer and the Reporting Person agreed to cancel the restricted stock unit award prior to the vesting of such award in exchange for cash.
F3 Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
F4 The restricted stock unit award was cancelled as of November 7, 2022 prior to any vesting or exercisability thereof.